Suppr超能文献

[两种不同剂量左甲状腺素 - 碘组合治疗甲状腺功能正常的弥漫性甲状腺肿的疗效比较]

[Comparison of the effectiveness of two different dosages of levothyroxine-iodide combinations for the therapy of euthyroid diffuse goiter].

作者信息

Kreissl M, Tiemann M, Hänscheid H, Rendl J, Reiners C

机构信息

Klinik und Poliklinik für Nuklearmedizin, Julius-Maximilians-Universität Würzburg.

出版信息

Dtsch Med Wochenschr. 2001 Mar 2;126(9):227-31. doi: 10.1055/s-2001-11478.

Abstract

BACKGROUND AND OBJECTIVE

Administration of levothyroxine and/or iodide can effectively reduce the volume of endemic goitre. However, TSH suppression during levothyroxine treatment may increase the number of recurrences through the persistence of intrathyroidal iodine deficiency. With special attention paid to the level of levothyroxine, a comparison was made of two dosages of combined levothyroxine and iodide.

PATIENTS AND METHODS

44 patients with diffuse euthyroid goitre were randomized to two treatment groups. Group A received 100 micrograms levothyroxine + 100 micrograms iodide, group B 75 micrograms levothyroxine + 150 micrograms iodide, all of them for three months. This was followed by three months without the medication. Intrathyroidal iodine concentration was measured at the onset of the study, then three months and six months later. At these same times thyroid volume was measured by ultrasound, as well as urinary iodine and various parameters of thyroid function.

RESULTS

Thyroid gland volume was reduced in both groups (group A: -17.3%; group B: -14.8%; p < 0.001). There was no significant difference of intrathyroidal iodine concentration and thyroid volume between both groups. After the treatment period, TSH suppression was more marked in group A, while TSH rise was greater in group B.

CONCLUSIONS

Both drug combinations resulted in comparable reduction of thyroid volume, while the intrathyroid concentration of iodine remained unchanged. The smaller rise of TSH after the treatment suggests that the dosage of 75 micrograms levothyroxine + 150 micrograms iodine is to be preferred.

摘要

背景与目的

左甲状腺素和/或碘化物的给药可有效减少地方性甲状腺肿的体积。然而,左甲状腺素治疗期间促甲状腺激素(TSH)抑制可能会因甲状腺内碘缺乏持续存在而增加复发次数。特别关注左甲状腺素水平,对两种剂量的左甲状腺素与碘化物联合用药进行了比较。

患者与方法

44例弥漫性甲状腺功能正常的甲状腺肿患者被随机分为两个治疗组。A组接受100微克左甲状腺素 + 100微克碘化物,B组接受75微克左甲状腺素 + 150微克碘化物,均治疗三个月。随后三个月停药。在研究开始时、三个月后和六个月后测量甲状腺内碘浓度。在这些相同时间,通过超声测量甲状腺体积,以及尿碘和甲状腺功能的各种参数。

结果

两组甲状腺体积均减小(A组:-17.3%;B组:-14.8%;p < 0.001)。两组甲状腺内碘浓度和甲状腺体积无显著差异。治疗期后,A组TSH抑制更明显,而B组TSH升高更大。

结论

两种药物组合导致甲状腺体积减小程度相当,而甲状腺内碘浓度保持不变。治疗后TSH较小幅度的升高表明,75微克左甲状腺素 + 150微克碘的剂量更可取。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验